Graphical Tasks to Measure Upper Limb Function in Patients with Parkinson's Disease

Validity and Response to Dopaminergic Medication

Esther J. Smits, Antti J. Tolonen, Luc Cluitmans, Mark van Gils, Rutger C. Zietsma, Robbert W.K. Borgemeester, Teus van Laar, Natasha M. Maurits

Research output: Contribution to journalArticleScientificpeer-review

7 Citations (Scopus)

Abstract

The most widely used method to assess motor functioning in Parkinson's disease (PD) patients is the unified Parkinson's disease rating scale-III (UPDRS-III). The UPDRS-III has limited ability to detect subtle changes in motor symptoms. Alternatively, graphical tasks can be used to provide objective measures of upper limb motor dysfunction. This study investigated the validity of such graphical tasks to assess upper limb function in PD patients and their ability to detect subtle changes in performance. Fourteen PD patients performed graphical tasks before and after taking dopaminergic medication. Graphical tasks included figure tracing, writing, and a modified Fitts' task. The Purdue pegboard test was performed to validate these graphical tasks. Movement time (MT), writing size, and the presence of tremor were assessed. MT on the graphical tasks correlated significantly with performance on the Purdue pegboard test (Spearman's ρ > 0.65; p < 0.05). MT decreased significantly after the intake of dopaminergic medication. Tremor power decreased after taking dopaminergic medication in most PD patients who suffered from tremor. Writing size did not correlate with performance on the Purdue pegboard test, nor did it change after taking medication. Our set of graphical tasks is valid to assess upper limb function in PD patients. MT proved to be the most useful measure for this purpose. The response on dopaminergic medication was optimally reflected by an improved MT on the graphical tasks in combination with a decreased tremor power, whereas writing size did not respond to dopaminergic treatment.

Original languageEnglish
Pages (from-to)283-289
JournalIEEE Journal of Biomedical and Health Informatics
Volume21
Issue number1
DOIs
Publication statusPublished - 1 Jan 2017
MoE publication typeA1 Journal article-refereed

Fingerprint

Upper Extremity
Parkinson Disease
Tremor

Keywords

  • Parkinson's disease
  • tremor
  • graphical tasks
  • upper limb function
  • bradykinesia
  • drawing
  • handwriting
  • micrographia
  • validity

Cite this

@article{055367fb1de74b8db40234900597d9fa,
title = "Graphical Tasks to Measure Upper Limb Function in Patients with Parkinson's Disease: Validity and Response to Dopaminergic Medication",
abstract = "The most widely used method to assess motor functioning in Parkinson's disease (PD) patients is the unified Parkinson's disease rating scale-III (UPDRS-III). The UPDRS-III has limited ability to detect subtle changes in motor symptoms. Alternatively, graphical tasks can be used to provide objective measures of upper limb motor dysfunction. This study investigated the validity of such graphical tasks to assess upper limb function in PD patients and their ability to detect subtle changes in performance. Fourteen PD patients performed graphical tasks before and after taking dopaminergic medication. Graphical tasks included figure tracing, writing, and a modified Fitts' task. The Purdue pegboard test was performed to validate these graphical tasks. Movement time (MT), writing size, and the presence of tremor were assessed. MT on the graphical tasks correlated significantly with performance on the Purdue pegboard test (Spearman's ρ > 0.65; p < 0.05). MT decreased significantly after the intake of dopaminergic medication. Tremor power decreased after taking dopaminergic medication in most PD patients who suffered from tremor. Writing size did not correlate with performance on the Purdue pegboard test, nor did it change after taking medication. Our set of graphical tasks is valid to assess upper limb function in PD patients. MT proved to be the most useful measure for this purpose. The response on dopaminergic medication was optimally reflected by an improved MT on the graphical tasks in combination with a decreased tremor power, whereas writing size did not respond to dopaminergic treatment.",
keywords = "Parkinson's disease, tremor, graphical tasks, upper limb function, bradykinesia, drawing, handwriting, micrographia, validity",
author = "Smits, {Esther J.} and Tolonen, {Antti J.} and Luc Cluitmans and {van Gils}, Mark and Zietsma, {Rutger C.} and Borgemeester, {Robbert W.K.} and {van Laar}, Teus and Maurits, {Natasha M.}",
note = "Project code: 73744 ISI: MEDICAL INFORMATICS",
year = "2017",
month = "1",
day = "1",
doi = "10.1109/JBHI.2015.2503802",
language = "English",
volume = "21",
pages = "283--289",
journal = "IEEE Journal of Biomedical and Health Informatics",
issn = "2168-2208",
publisher = "Institute of Electrical and Electronic Engineers IEEE",
number = "1",

}

Graphical Tasks to Measure Upper Limb Function in Patients with Parkinson's Disease : Validity and Response to Dopaminergic Medication. / Smits, Esther J.; Tolonen, Antti J.; Cluitmans, Luc; van Gils, Mark; Zietsma, Rutger C.; Borgemeester, Robbert W.K.; van Laar, Teus; Maurits, Natasha M.

In: IEEE Journal of Biomedical and Health Informatics, Vol. 21, No. 1, 01.01.2017, p. 283-289.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Graphical Tasks to Measure Upper Limb Function in Patients with Parkinson's Disease

T2 - Validity and Response to Dopaminergic Medication

AU - Smits, Esther J.

AU - Tolonen, Antti J.

AU - Cluitmans, Luc

AU - van Gils, Mark

AU - Zietsma, Rutger C.

AU - Borgemeester, Robbert W.K.

AU - van Laar, Teus

AU - Maurits, Natasha M.

N1 - Project code: 73744 ISI: MEDICAL INFORMATICS

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The most widely used method to assess motor functioning in Parkinson's disease (PD) patients is the unified Parkinson's disease rating scale-III (UPDRS-III). The UPDRS-III has limited ability to detect subtle changes in motor symptoms. Alternatively, graphical tasks can be used to provide objective measures of upper limb motor dysfunction. This study investigated the validity of such graphical tasks to assess upper limb function in PD patients and their ability to detect subtle changes in performance. Fourteen PD patients performed graphical tasks before and after taking dopaminergic medication. Graphical tasks included figure tracing, writing, and a modified Fitts' task. The Purdue pegboard test was performed to validate these graphical tasks. Movement time (MT), writing size, and the presence of tremor were assessed. MT on the graphical tasks correlated significantly with performance on the Purdue pegboard test (Spearman's ρ > 0.65; p < 0.05). MT decreased significantly after the intake of dopaminergic medication. Tremor power decreased after taking dopaminergic medication in most PD patients who suffered from tremor. Writing size did not correlate with performance on the Purdue pegboard test, nor did it change after taking medication. Our set of graphical tasks is valid to assess upper limb function in PD patients. MT proved to be the most useful measure for this purpose. The response on dopaminergic medication was optimally reflected by an improved MT on the graphical tasks in combination with a decreased tremor power, whereas writing size did not respond to dopaminergic treatment.

AB - The most widely used method to assess motor functioning in Parkinson's disease (PD) patients is the unified Parkinson's disease rating scale-III (UPDRS-III). The UPDRS-III has limited ability to detect subtle changes in motor symptoms. Alternatively, graphical tasks can be used to provide objective measures of upper limb motor dysfunction. This study investigated the validity of such graphical tasks to assess upper limb function in PD patients and their ability to detect subtle changes in performance. Fourteen PD patients performed graphical tasks before and after taking dopaminergic medication. Graphical tasks included figure tracing, writing, and a modified Fitts' task. The Purdue pegboard test was performed to validate these graphical tasks. Movement time (MT), writing size, and the presence of tremor were assessed. MT on the graphical tasks correlated significantly with performance on the Purdue pegboard test (Spearman's ρ > 0.65; p < 0.05). MT decreased significantly after the intake of dopaminergic medication. Tremor power decreased after taking dopaminergic medication in most PD patients who suffered from tremor. Writing size did not correlate with performance on the Purdue pegboard test, nor did it change after taking medication. Our set of graphical tasks is valid to assess upper limb function in PD patients. MT proved to be the most useful measure for this purpose. The response on dopaminergic medication was optimally reflected by an improved MT on the graphical tasks in combination with a decreased tremor power, whereas writing size did not respond to dopaminergic treatment.

KW - Parkinson's disease

KW - tremor

KW - graphical tasks

KW - upper limb function

KW - bradykinesia

KW - drawing

KW - handwriting

KW - micrographia

KW - validity

UR - http://www.scopus.com/inward/record.url?scp=85019259920&partnerID=8YFLogxK

U2 - 10.1109/JBHI.2015.2503802

DO - 10.1109/JBHI.2015.2503802

M3 - Article

VL - 21

SP - 283

EP - 289

JO - IEEE Journal of Biomedical and Health Informatics

JF - IEEE Journal of Biomedical and Health Informatics

SN - 2168-2208

IS - 1

ER -